Deerfield Partners, L.P., 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 339,537 shares at $4.62 ($1.6M) on 2019-06-21, disclosed to the SEC on 2019-06-25.
Open-market sale of $1.6M ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.62 | 70,135 | $324K | 20.7% |
| 2 | $4.62 | 269,402 | $1.2M | 79.3% |
| Total | $4.62 avg | 339,537 | $1.6M | 100% |
| Filing → |
| BDTX | BUY | 2020-02-03 | $7.6M | — | Filing → |
| FIXX | SELL | 2020-01-31 | $16.0M | — | Filing → |
| ACRS | SELL | 2019-06-25 | $286K | — | Filing → |